BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:RNA therapeutics is a rapidly expanding industry with increasi ngly growing potential for immunotherapy personalised medicines\, and tre atment of genetic\, infectious and chronic diseases. This is reflected wi th the value of the global antisense &\; RNA therapeutics market expec ted to reach USD 1.81 billion by 2025\, growing at a CAGR of 7.5%. Furthe rmore\, the recent advent of CRISPR\, an RNA-guided gene-editing technolo gy\, as well as new strides in the delivery of messenger RNA transcribed in vitro\, have triggered a major expansion of the RNA-therapeutics field .\n\nThe 2021 conference is set to explore the latest developments in RNA delivery agents and RNA-based therapeutics with the latest case studies on advanced mRNA technologies\, oligonucleotide delivery\, therapeutic ap plications and future trends and innovations.\n\nJoin us in February 2021 \, as SMi’s 12th annual RNA Therapeutics Conference brings together indus try experts from leading RNA therapeutics companies to gain an expert and holistic view on the latest developments in the industry\, upcoming regu latory updates and industry implications.\n\nBENEFITS OF ATTENDING:\n\n\n Explore in industry insights into how mRNA is being used to combat COVID- 19\nEngage in case studies exploring the growing therapeutic potential of RNA for rare diseases\nDelve into future trends in AI application for op timal RNA therapeutics\nHear regulatory outlooks of the RNA landscape\, c linical trials and looking ahead\n\nView the full agenda and speaker line -up online: www.therapeutics-rna.com/pharmiwl\n\n \;\n\nChairs for 20 21:\n\nHeinrich Haas\, VP RNA Formulation and Drug Delivery\, BioNTech\n\ nFocus Day Chair for 2021: Shalini Andersson\, Chief Scientist New Therap eutic Modalities &\; Head of Oligonucleotide Discovery\, AstraZeneca\n \n \;\n\nFeatured speakers: \n\n\nDong Yu\, Fellow\, Senior Director\ , and Head\, GSK Vaccines\nMaria Luisa Pineda\, CEO and Co-Founder\, Envi sagenics\nKirsty Wydenbach\, Deputy Unit Manager/Senior Medical Assessor\ , MHRA\nDong Ki Lee\, CEO\, OliX\nJennifer Pluim\, Vice President Medical Affairs\, ProQR\nArpan Desai\, Team Leader\, Advanced Drug Delivery\, Ph armaceutical Sciences\, AstraZeneca\nRuchi Shah\, Senior Research Enginee r\, New Therapeutics Modalities\, Eli Lilly and Company\nMichael Mulqueen \, Vice President Business Development\, eTheRNA immunotherapies\nTroels Koch\, Founder &\; CEO\, Aqiventa\n\nWho should attend:\n\n\nResearch &\; Development Directors/Managers/Scientists\nHeads of Clinical Devel opment\nHeads of Pre-Clinical Development\nHead of RNA Biology\nHead of R NA Formulation and Drug Delivery\nHead of Pre-clinical R&\;D\nHead of New Modalities\nHead of Discovery\nSenior Scientists\nChief Scientific Of ficers\nChief Medical Officers\n\nAdditional Contact Info:\n\nT: +44 (0)2 0 7827 6088\n\nE:hsidhu@smi-online.co.uk Follow us: @SMiPharm #SMirna\n DTEND:20210211T040000 DTSTAMP:20260512T232952Z DTSTART:20210210T083000 LOCATION:\, SEQUENCE:0 SUMMARY:RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy personalised medicines\, and treatme nt of gen... UID:98faa4e5-fb6f-4d10-972c-60e1e6428cfb END:VEVENT END:VCALENDAR